AMOXICILLINE TEVA 1 g, dispersible tablet 14 tablets
Active ingredients: Amoxicillin, Amoxicillin trihydrate
Commercialized according to BDPMDispensing in France: Prescription only
Dispersible tablet14 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- AMOXICILLINE TEVA 1 g, comprimé dispersible
- Pharmaceutical form
- comprimé dispersible
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC PVDC aluminium de 14 comprimé(s)
- Marketing authorisation holder
- TEVA (PAYS-BAS)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 26 Apr 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65253528CIP73882934CIP133400938829341Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| AMOXICILLINEcomprimé | 1 g · un comprimé | FT |
| AMOXICILLINE TRIHYDRATÉEcomprimé | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.